TEVA icon

Teva Pharmaceuticals
TEVA

Overview Fund Activity

452 hedge funds and large institutions have $5.91B invested in Teva Pharmaceuticals in 2019 Q2 according to their latest regulatory filings, with 46 funds opening new positions, 160 increasing their positions, 137 reducing their positions, and 110 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
452
Holders Change
-69
Holders Change %
-13.24%
% of All Funds
9.83%
Holding in Top 10
6
Holding in Top 10 Change
-7
Holding in Top 10 Change %
-53.85%
% of All Funds
0.13%
New
46
Increased
160
Reduced
137
Closed
110
Calls
$255M
Puts
$309M
Net Calls
-$54.5M
Net Calls Change
-$19.6M

Top Buyers

1
Renaissance Technologies
Renaissance Technologies
New York
+$66.1M
2
Morgan Stanley
Morgan Stanley
New York
+$47.4M
3
Wellington Management Group
Wellington Management Group
Massachusetts
+$41M
4
CS
Credit Suisse
Switzerland
+$37.2M
5
Nuveen Asset Management
Nuveen Asset Management
Illinois
+$32.6M

Top Sellers

1
BC
Brahman Capital
New York
-$111M
2
Fidelity Investments
Fidelity Investments
Massachusetts
-$101M
3
HCM
Highfields Capital Management
Massachusetts
-$83M
4
PCM
Polaris Capital Management
Massachusetts
-$70.1M
5
Capital World Investors
Capital World Investors
California
-$64.8M
Name Holding Trade Value Shares
Change 		Shares
Change %
CB
551
CNB Bank
Pennsylvania
– -$1K -49 Closed
TC
552
Truvestments Capital
Florida
– -$1K -41 Closed
LFA
553
Legacy Financial Advisors
Kentucky
– -$1K -40 Closed
19 20 21 22
23